Trial Profile
An observational, longitudinal, multicenter cohort study assessing the current management of hemoglobin (Hb) levels in cancer patients with symptomatic chemotherapy-induced anemia (CIA) treated with darbepoetin alfa
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2018
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia; Breast cancer
- Focus Therapeutic Use
- 29 Jun 2018 New trial record